Skip to main content
Figure 7 | Arthritis Research & Therapy

Figure 7

From: Infliximab: 12 years of experience

Figure 7

Ankylosing spondylitis: improvement in disease activity. Infliximab sustains improvement in disease activity over 5 years. At 156 weeks, n = 43 patients; at 254 weeks, n = 38. ASAS, Assessment of SpondyloArthritis International Society; BASDAI, Bath Ankylosing Spondylitis Disease Activity Index; IFX, infliximab. Modified with permission from [74].

Back to article page